Skip to main content
. Author manuscript; available in PMC: 2016 Sep 28.
Published in final edited form as: Cancer Lett. 2015 Jun 25;366(1):44–51. doi: 10.1016/j.canlet.2015.05.034

Fig. 8.

Fig. 8

Schematic diagram of 4 major cellular pathways targeted by YM155 treatment in tumor cells [10]. Red molecules were shown to be differentially affected by YM155 exposure in this study, and represent the changes observed in YM155-sensitive HL60 cells (↑ = up-regulation; ↓ = down-regulation). Dashed lines represent a hypothetical mechanism by which constitutive AKT signaling in U937 cells may help protect specific YM155 targets [27,28,4042] resulting in a treatment resistant phenotype. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)